135 related articles for article (PubMed ID: 35796429)
1. Nanodrugs Incorporating LDHA siRNA Inhibit M2-like Polarization of TAMs and Amplify Autophagy to Assist Oxaliplatin Chemotherapy against Colorectal Cancer.
Hu L; Huang S; Chen G; Li B; Li T; Lin M; Huang Y; Xiao Z; Shuai X; Su Z
ACS Appl Mater Interfaces; 2022 Jul; 14(28):31625-31633. PubMed ID: 35796429
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Associated Macrophages Promote Oxaliplatin Resistance
Lan H; Liu Y; Liu J; Wang X; Guan Z; Du J; Jin K
Mol Pharm; 2021 Mar; 18(3):1026-1037. PubMed ID: 33555197
[TBL] [Abstract][Full Text] [Related]
3. PFKFB3 Inhibition Attenuates Oxaliplatin-Induced Autophagy and Enhances Its Cytotoxicity in Colon Cancer Cells.
Yan S; Zhou N; Zhang D; Zhang K; Zheng W; Bao Y; Yang W
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671668
[TBL] [Abstract][Full Text] [Related]
4. Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape.
Ma Y; Guo C; Wang X; Wei X; Ma J
J Exp Clin Cancer Res; 2023 Sep; 42(1):237. PubMed ID: 37697332
[TBL] [Abstract][Full Text] [Related]
5. TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages.
Liu Z; Xie Y; Xiong Y; Liu S; Qiu C; Zhu Z; Mao H; Yu M; Wang X
Cancer Lett; 2020 Jan; 469():173-185. PubMed ID: 31629935
[TBL] [Abstract][Full Text] [Related]
6. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer.
Huang CZ; Zhou Y; Tong QS; Duan QJ; Zhang Q; Du JZ; Yao XQ
Biomaterials; 2022 Nov; 290():121827. PubMed ID: 36228517
[TBL] [Abstract][Full Text] [Related]
7. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.
Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L
Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471
[TBL] [Abstract][Full Text] [Related]
8. ATB
Chen Z; Chen H; Huang L; Duan B; Dai S; Cai W; Sun M; Jiang Z; Lu R; Jiang Y; Jiang X; Zheng H; Yao Q; Kim K; Lin G; Xie C; Chu M; Chen R; Kou L
Int J Pharm; 2023 Jun; 641():123082. PubMed ID: 37244464
[TBL] [Abstract][Full Text] [Related]
9. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
[TBL] [Abstract][Full Text] [Related]
10. Autophagy drives plasticity and functional polarization of tumor-associated macrophages.
Kuo WT; Chang JM; Chen CC; Tsao N; Chang CP
IUBMB Life; 2022 Feb; 74(2):157-169. PubMed ID: 34467634
[TBL] [Abstract][Full Text] [Related]
11. Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17.
Zhang A; Xu Y; Xu H; Ren J; Meng T; Ni Y; Zhu Q; Zhang WB; Pan YB; Jin J; Bi Y; Wu ZB; Lin S; Lou M
Theranostics; 2021; 11(8):3839-3852. PubMed ID: 33664865
[No Abstract] [Full Text] [Related]
12. Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma.
Fu XT; Song K; Zhou J; Shi YH; Liu WR; Shi GM; Gao Q; Wang XY; Ding ZB; Fan J
Cancer Cell Int; 2019; 19():71. PubMed ID: 30962765
[TBL] [Abstract][Full Text] [Related]
13. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
14. On-Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin-Induced Cancer Immunotherapy.
Wang X; Li M; Ren K; Xia C; Li J; Yu Q; Qiu Y; Lu Z; Long Y; Zhang Z; He Q
Adv Mater; 2020 Aug; 32(32):e2002160. PubMed ID: 32596861
[TBL] [Abstract][Full Text] [Related]
15. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
17. Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel.
Ren Y; Li X; Han B; Zhao N; Mu M; Wang C; Du Y; Wang Y; Tong A; Liu Y; Zhou L; You C; Guo G
Eur J Pharm Sci; 2019 Feb; 128():279-289. PubMed ID: 30553061
[TBL] [Abstract][Full Text] [Related]
18. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization.
Li Z; Fu WJ; Chen XQ; Wang S; Deng RS; Tang XP; Yang KD; Niu Q; Zhou H; Li QR; Lin Y; Liang M; Li SS; Ping YF; Liu XD; Bian XW; Yao XH
J Exp Clin Cancer Res; 2022 Feb; 41(1):74. PubMed ID: 35193644
[TBL] [Abstract][Full Text] [Related]
19. Manipulating the function of tumor-associated macrophages by siRNA-loaded lipid nanoparticles for cancer immunotherapy.
Shobaki N; Sato Y; Suzuki Y; Okabe N; Harashima H
J Control Release; 2020 Sep; 325():235-248. PubMed ID: 32649972
[TBL] [Abstract][Full Text] [Related]
20. Metformin increases the cytotoxicity of oxaliplatin in human DLD-1 colorectal cancer cells through down-regulating HMGB1 expression.
Huang WS; Lin CT; Chen CN; Chang SF; Chang HI; Lee KC
J Cell Biochem; 2018 Aug; 119(8):6943-6952. PubMed ID: 29737584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
